{"title":"应用增强反搏治疗难治性心绞痛和充血性心力衰竭。","authors":"Anil Kumar, Wilbert S Aronow","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Enhanced external counterpulsation (EECP) is a Food and Drug Administration approved non-pharmacological treatment for angina pectoris refractory to medical management and for use in the treatment of congestive heart failure. EECP improves quality of life, symptoms and exercise duration in these patients.</p>","PeriodicalId":75729,"journal":{"name":"Comprehensive therapy","volume":"35 3-4","pages":"133-8"},"PeriodicalIF":0.0000,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of enhanced counterpulsation in the treatment of refractory angina pectoris and congestive heart failure.\",\"authors\":\"Anil Kumar, Wilbert S Aronow\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Enhanced external counterpulsation (EECP) is a Food and Drug Administration approved non-pharmacological treatment for angina pectoris refractory to medical management and for use in the treatment of congestive heart failure. EECP improves quality of life, symptoms and exercise duration in these patients.</p>\",\"PeriodicalId\":75729,\"journal\":{\"name\":\"Comprehensive therapy\",\"volume\":\"35 3-4\",\"pages\":\"133-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Comprehensive therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Comprehensive therapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Use of enhanced counterpulsation in the treatment of refractory angina pectoris and congestive heart failure.
Enhanced external counterpulsation (EECP) is a Food and Drug Administration approved non-pharmacological treatment for angina pectoris refractory to medical management and for use in the treatment of congestive heart failure. EECP improves quality of life, symptoms and exercise duration in these patients.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
